BETA ZEN
Caspase 2
Texto da Wikipédia (en), licença CC BY-SA. O BETARUBI mostra o verbete inteiro nesta página — a leitura não continua fora do site.
| Caspase-2 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Identifiers | |||||||||
| EC no. | 3.4.22.55 | ||||||||
| CAS no. | 182372-14-1 | ||||||||
| Databases | |||||||||
| BRENDA | enzyme data | ||||||||
| ExPASy | NiceZyme view | ||||||||
| KEGG | enzyme entry | ||||||||
| MetaCyc | metabolic pathway | ||||||||
| Rhea | reactions | ||||||||
| PDB structures | RCSB PDB PDBe PDBsum | ||||||||
| |||||||||
Caspase 2 (EC 3.4.22.55), also known as ICH-1, NEDD-2, caspase-2L, caspase-2S, neural precursor cell expressed developmentally down-regulated protein 2, CASP-2, or NEDD2 protein, is an enzyme that, in humans, is encoded by the CASP2 gene.[5] CASP2 orthologs[6] have been identified in nearly all mammals for which complete genome data are available. Unique orthologs are also present in birds, lizards, lissamphibians, and teleosts.
Function
Caspase-2 is an initiator caspase, as are caspase-8 (EC 3.4.22.61), caspase-9 (EC 3.4.22.62) and caspase-10 (EC 3.4.22.63).
Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes that undergo proteolytic processing at conserved aspartic residues to produce two subunits, large and small, that dimerize to form the active enzyme. The proteolytic cleavage of this protein is induced by a variety of apoptotic stimuli.[7]
Caspase 2 proteolytically cleaves other proteins. It belongs to a family of cysteine proteases called caspases that cleave proteins only at an amino acid following an aspartic acid residue. Within this family, caspase 2 is part of the Ich-1 subfamily. It is one of the most conserved caspases in different species of animal. Caspase 2 has a similar amino acid sequence to initiator caspases, including caspase 1, caspase 4, caspase 5, and caspase 9. It is produced as a zymogen, which contains a long pro-domain that is similar to that of caspase 9 and contains a protein interaction domain known as a CARD domain. Pro-caspase-2 contains two subunits, p19 and p12.
It has been shown to associate with several proteins involved in apoptosis using its CARD domain, including RIP-associated Ich-1/Ced-3-homologue protein with a death domain (RAIDD), apoptosis repressor with caspase recruitment domain (ARC), and death effector filament-forming Ced-4-like apoptosis protein (DEFCAP).[8] Together with RAIDD and p53-induced protein with a death domain ([PIDD])(LRDD), caspase 2 has been shown to form the so-called PIDDosome,[9] which may serve as an activation platform for the protease, although it may also be activated in the absence of PIDD.[10] Overall, caspase 2 appears to be a very versatile caspase with multiple functions beyond cell death induction.[11][12]
Caspase-2 is an important enzyme in the cysteine aspartate protease family, known as caspases, which are central to the regulation of apoptosis and, in certain cases, inflammation. While many caspases are mainly involved in the initiation and execution of cell death, caspase-2 has a broader range of functions. Beyond its apoptotic role, it contributes to maintaining genomic stability and responding to cellular stress, demonstrating its multifaceted role in cellular processes and its wider importance in cell regulation mechanisms.[13] When caspases are activated, they break down a variety of specific protein substrates, triggering the distinct features of apoptosis, such as DNA fragmentation, chromatin condensation, and plasma membrane blebbing. Caspase-2, known as the most evolutionarily conserved caspase, holds a unique role in both apoptotic and non-apoptotic functions. Its evolutionary stability highlights its essential contributions to cellular processes like preserving genomic integrity and regulating stress responses, demonstrating its broader significance beyond just apoptosis.[12]
Activation through dimerization
Caspases are classified into two fundamental groups: initiator caspases, including caspase-8 and caspase-9, and executioner caspases, such as caspase-3 and caspase-7, each playing distinct roles in the apoptosis signaling pathway.[14] Initiator caspases serve as critical regulators at the top of various signaling cascades, orchestrating the activation of executioner caspases through both direct and indirect mechanisms. While these caspases are typically found as inactive monomers within the cell, their activation relies on dimerization. This dimerization occurs when initiator caspases are recruited to large protein complexes that function as intricate signaling platforms, enabling their conversion to an active form.[15] Caspases are produced as single-chain pro-caspases that undergo cleavage within their chains, resulting in the formation of large and small catalytic subunits. Although this cleavage is both necessary and sufficient for activating executioner caspases, evidence indicates that initiator caspases require dimerization for activation. Furthermore, the intra-chain cleavage that follows this process helps to stabilize the active form of the enzyme.[16] Caspase-2 is activated via a mechanism that parallels those of other caspases. In its monomeric state, it shows no measurable activity, regardless of its cleavage status. Conversely, a dimeric form of a cleavage-deficient mutant retains about 20% of its enzymatic activity. Following autoprocessing of the dimerized form, caspase-2 becomes fully active.[17] Consequently, the first step in the activation of caspase-2 is dimerization.
Interactions
Caspase 2 has been shown to interact with:
See also
References
- 1 2 3 GRCh38: Ensembl release 89: ENSG00000106144 – Ensembl, May 2017
- 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000029863 – Ensembl, May 2017
- ↑ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ↑ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ↑ Kumar S, White DL, Takai S, Turczynowicz S, Juttner CA, Hughes TP (June 1995). "Apoptosis regulatory gene NEDD2 maps to human chromosome segment 7q34-35, a region frequently affected in haematological neoplasms". Human Genetics. 95 (6): 641–644. doi:10.1007/bf00209480. PMID 7789948. S2CID 22813779.
- ↑ "OrthoMaM phylogenetic marker: CASP2 coding sequence". Archived from the original on 24 September 2015. Retrieved 20 December 2009.
- ↑ "Entrez Gene: CASP2".
- ↑ Zhivotovsky B, Orrenius S (2005). "Caspase-2 function in response to DNA damage". Biochemical and Biophysical Research Communications. 331 (3): 859–867. doi:10.1016/j.bbrc.2005.03.191. PMID 15865942.
- 1 2 Tinel A, Tschopp J (May 2004). "The PIDDosome, a protein complex implicated in activation of caspase-2 in response to genotoxic stress". Science. 304 (5672). New York, N.Y.: 843–846. Bibcode:2004Sci...304..843T. doi:10.1126/science.1095432. PMID 15073321. S2CID 6583298.
- ↑ Manzl C, Krumschnabel G, Bock F, Sohm B, Labi V, Baumgartner F, et al. (April 2009). "Caspase-2 activation in the absence of PIDDosome formation". The Journal of Cell Biology. 185 (2): 291–303. doi:10.1083/jcb.200811105. PMC 2700374. PMID 19364921.
- ↑ Krumschnabel G, Manzl C, Villunger A (September 2009). "Caspase-2: killer, savior and safeguard--emerging versatile roles for an ill-defined caspase". Oncogene. 28 (35): 3093–3096. doi:10.1038/onc.2009.173. PMC 3272399. PMID 19581929.
- 1 2 Krumschnabel G, Sohm B, Bock F, Manzl C, Villunger A (February 2009). "The enigma of caspase-2: the laymen's view". Cell Death and Differentiation. 16 (2): 195–207. doi:10.1038/cdd.2008.170. PMC 3272397. PMID 19023332.
- ↑ Creagh EM, Conroy H, Martin SJ (June 2003). "Caspase-activation pathways in apoptosis and immunity". Immunological Reviews. 193 (1): 10–21. doi:10.1034/j.1600-065x.2003.00048.x. PMID 12752666.
- ↑ Boatright KM, Salvesen GS (December 2003). "Mechanisms of caspase activation". Current Opinion in Cell Biology. 15 (6): 725–731. doi:10.1016/j.ceb.2003.10.009. PMID 14644197.
- ↑ Boatright KM, Renatus M, Scott FL, Sperandio S, Shin H, Pedersen IM, et al. (February 2003). "A unified model for apical caspase activation". Molecular Cell. 11 (2): 529–541. doi:10.1016/s1097-2765(03)00051-0. PMID 12620239.
- ↑ Chuh KN, Batt AR, Zaro BW, Darabedian N, Marotta NP, Brennan CK, et al. (June 2017). "The New Chemical Reporter 6-Alkynyl-6-deoxy-GlcNAc Reveals O-GlcNAc Modification of the Apoptotic Caspases That Can Block the Cleavage/Activation of Caspase-8". Journal of the American Chemical Society. 139 (23): 7872–7885. doi:10.1021/jacs.7b02213.s001. PMC 6225779. PMID 28528544.
- ↑ Baliga BC, Read SH, Kumar S (November 2004). "The biochemical mechanism of caspase-2 activation". Cell Death and Differentiation. 11 (11): 1234–1241. doi:10.1038/sj.cdd.4401492. PMID 15297885.
- 1 2 Guo Y, Srinivasula SM, Druilhe A, Fernandes-Alnemri T, Alnemri ES (April 2002). "Caspase-2 induces apoptosis by releasing proapoptotic proteins from mitochondria". The Journal of Biological Chemistry. 277 (16): 13430–13437. doi:10.1074/jbc.M108029200. PMID 11832478.
- ↑ Paroni G, Henderson C, Schneider C, Brancolini C (June 2001). "Caspase-2-induced apoptosis is dependent on caspase-9, but its processing during UV- or tumor necrosis factor-dependent cell death requires caspase-3". The Journal of Biological Chemistry. 276 (24): 21907–21915. doi:10.1074/jbc.M011565200. PMID 11399776.
- ↑ Droin N, Beauchemin M, Solary E, Bertrand R (December 2000). "Identification of a caspase-2 isoform that behaves as an endogenous inhibitor of the caspase cascade". Cancer Research. 60 (24): 7039–7047. PMID 11156409.
- ↑ Duan H, Dixit VM (January 1997). "RAIDD is a new 'death' adaptor molecule". Nature. 385 (6611): 86–89. Bibcode:1997Natur.385...86D. doi:10.1038/385086a0. hdl:2027.42/62739. PMID 8985253. S2CID 4317538.
- ↑ Srinivasula SM, Ahmad M, Fernandes-Alnemri T, Litwack G, Alnemri ES (December 1996). "Molecular ordering of the Fas-apoptotic pathway: the Fas/APO-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple Ced-3/ICE-like cysteine proteases". Proceedings of the National Academy of Sciences of the United States of America. 93 (25): 14486–14491. Bibcode:1996PNAS...9314486S. doi:10.1073/pnas.93.25.14486. PMC 26159. PMID 8962078.
This article incorporates text from the United States National Library of Medicine, which is in the public domain.
